Total: £ 56.28
Published Date: 2026-01-08 | Pages: 150 | Tables: 146 | Medical Care
The global Patient Recruitment for Clinical Trials market was valued at US$ 10655 million in 2025 and is anticipated to reach US$ 18228 million by 2032, at a CAGR of 8.1% from 2026 to 2032.
Patient recruitment for clinical trials refers to specialized services that support the identification, screening, enrollment, and management of study participants for clinical research projects. These services typically involve multi-channel patient outreach, eligibility pre-screening, informed consent support, and enrollment tracking, enabling sponsors, CROs, and research sites to meet recruitment targets within required timelines while ensuring protocol compliance and data quality.
The market is primarily driven by the increasing number and complexity of clinical trials. Rising investment in drug development and the rapid growth of innovative therapies—such as oncology, rare diseases, biologics, and cell and gene therapies—have led to stricter inclusion/exclusion criteria and more fragmented patient populations, increasing reliance on professional recruitment services. In parallel, pressure to reduce trial timelines and costs encourages sponsors to outsource recruitment to specialized providers with data-driven and operational expertise. The adoption of digital recruitment tools, real-world data, and patient-centric engagement strategies further improves recruitment efficiency and reach, supporting continued market growth.
This report delivers a comprehensive overview of the global Patient Recruitment for Clinical Trials market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Patient Recruitment for Clinical Trials. The Patient Recruitment for Clinical Trials market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Patient Recruitment for Clinical Trials market comprehensively. Regional market sizes by Clinical Trial Phase, by Therapeutic Area, by Client Type, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Patient Recruitment for Clinical Trials manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Clinical Trial Phase, by Therapeutic Area, and by region.
Market Segmentation
By Company
Antidote
M&B Sciences
Clariness
BBK Worldwide
Worldwide Clinical Trials
American Clinical Research Services
IQVIA
PPD Inc
Veristat
Elligo Health Research
AutoCruitment
Clinical Connection
Biorasi
Curavit Clinical Research
PatientEvolution
Trialmed
MMG
Science37
StudyKIK
Trialbee
Formation Bio
WCG Clinical Services
Trialfacts
Shanghai Jsure
Segment by Clinical Trial Phase
Phase I
Phase II
Phase III
Phase IV
Segment by Client Type
Pharmaceutical Companies
Biotechnology Companies
CROs and Research Organizations
Segment by Recruitment Channel
Online
Offline
Segment by Therapeutic Area
Oncology Clinical Trials
Rare Disease Clinical Trials
Chronic and Common Disease Clinical Trials
CNS and Psychiatric Clinical Trials
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Clinical Trial Phase, by Therapeutic Area, by Client Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Patient Recruitment for Clinical Trials companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Clinical Trial Phase, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Therapeutic Area, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Clinical Trial Phase
1.2.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Clinical Trial Phase: 2021 vs 2025 vs 2032
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Client Type
1.3.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Client Type: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 CROs and Research Organizations
1.4 Market by Recruitment Channel
1.4.1 Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Recruitment Channel: 2021 vs 2025 vs 2032
1.4.2 Online
1.4.3 Offline
1.5 Market by Therapeutic Area
1.5.1 Global Patient Recruitment for Clinical Trials Market Growth by Therapeutic Area: 2021 vs 2025 vs 2032
1.5.2 Oncology Clinical Trials
1.5.3 Rare Disease Clinical Trials
1.5.4 Chronic and Common Disease Clinical Trials
1.5.5 CNS and Psychiatric Clinical Trials
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Patient Recruitment for Clinical Trials Market Perspective (2021–2032)
2.2 Global Patient Recruitment for Clinical Trials Growth Trends by Region
2.2.1 Global Patient Recruitment for Clinical Trials Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Patient Recruitment for Clinical Trials Historic Market Size by Region (2021–2026)
2.2.3 Patient Recruitment for Clinical Trials Forecasted Market Size by Region (2027–2032)
2.3 Patient Recruitment for Clinical Trials Market Dynamics
2.3.1 Patient Recruitment for Clinical Trials Industry Trends
2.3.2 Patient Recruitment for Clinical Trials Market Drivers
2.3.3 Patient Recruitment for Clinical Trials Market Challenges
2.3.4 Patient Recruitment for Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient Recruitment for Clinical Trials Players by Revenue
3.1.1 Global Top Patient Recruitment for Clinical Trials Players by Revenue (2021–2026)
3.1.2 Global Patient Recruitment for Clinical Trials Revenue Market Share by Players (2021–2026)
3.2 Global Top Patient Recruitment for Clinical Trials Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Patient Recruitment for Clinical Trials Revenue
3.4 Global Patient Recruitment for Clinical Trials Market Concentration Ratio
3.4.1 Global Patient Recruitment for Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient Recruitment for Clinical Trials Revenue in 2025
3.5 Global Key Players of Patient Recruitment for Clinical Trials Head Offices and Areas Served
3.6 Global Key Players of Patient Recruitment for Clinical Trials, Products and Applications
3.7 Global Key Players of Patient Recruitment for Clinical Trials, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Patient Recruitment for Clinical Trials Breakdown Data by Clinical Trial Phase
4.1 Global Patient Recruitment for Clinical Trials Historic Market Size by Clinical Trial Phase (2021–2026)
4.2 Global Patient Recruitment for Clinical Trials Forecasted Market Size by Clinical Trial Phase (2027–2032)
5 Patient Recruitment for Clinical Trials Breakdown Data by Therapeutic Area
5.1 Global Patient Recruitment for Clinical Trials Historic Market Size by Therapeutic Area (2021–2026)
5.2 Global Patient Recruitment for Clinical Trials Forecasted Market Size by Therapeutic Area (2027–2032)
6 North America
6.1 North America Patient Recruitment for Clinical Trials Market Size (2021–2032)
6.2 North America Patient Recruitment for Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Patient Recruitment for Clinical Trials Market Size by Country (2021–2026)
6.4 North America Patient Recruitment for Clinical Trials Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Patient Recruitment for Clinical Trials Market Size (2021–2032)
7.2 Europe Patient Recruitment for Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Patient Recruitment for Clinical Trials Market Size by Country (2021–2026)
7.4 Europe Patient Recruitment for Clinical Trials Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Patient Recruitment for Clinical Trials Market Size (2021–2032)
8.2 Asia-Pacific Patient Recruitment for Clinical Trials Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (2021–2026)
8.4 Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Patient Recruitment for Clinical Trials Market Size (2021–2032)
9.2 Latin America Patient Recruitment for Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Patient Recruitment for Clinical Trials Market Size by Country (2021–2026)
9.4 Latin America Patient Recruitment for Clinical Trials Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient Recruitment for Clinical Trials Market Size (2021–2032)
10.2 Middle East & Africa Patient Recruitment for Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (2021–2026)
10.4 Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Antidote
11.1.1 Antidote Company Details
11.1.2 Antidote Business Overview
11.1.3 Antidote Patient Recruitment for Clinical Trials Introduction
11.1.4 Antidote Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.1.5 Antidote Recent Development
11.2 M&B Sciences
11.2.1 M&B Sciences Company Details
11.2.2 M&B Sciences Business Overview
11.2.3 M&B Sciences Patient Recruitment for Clinical Trials Introduction
11.2.4 M&B Sciences Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.2.5 M&B Sciences Recent Development
11.3 Clariness
11.3.1 Clariness Company Details
11.3.2 Clariness Business Overview
11.3.3 Clariness Patient Recruitment for Clinical Trials Introduction
11.3.4 Clariness Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.3.5 Clariness Recent Development
11.4 BBK Worldwide
11.4.1 BBK Worldwide Company Details
11.4.2 BBK Worldwide Business Overview
11.4.3 BBK Worldwide Patient Recruitment for Clinical Trials Introduction
11.4.4 BBK Worldwide Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.4.5 BBK Worldwide Recent Development
11.5 Worldwide Clinical Trials
11.5.1 Worldwide Clinical Trials Company Details
11.5.2 Worldwide Clinical Trials Business Overview
11.5.3 Worldwide Clinical Trials Patient Recruitment for Clinical Trials Introduction
11.5.4 Worldwide Clinical Trials Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.5.5 Worldwide Clinical Trials Recent Development
11.6 American Clinical Research Services
11.6.1 American Clinical Research Services Company Details
11.6.2 American Clinical Research Services Business Overview
11.6.3 American Clinical Research Services Patient Recruitment for Clinical Trials Introduction
11.6.4 American Clinical Research Services Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.6.5 American Clinical Research Services Recent Development
11.7 IQVIA
11.7.1 IQVIA Company Details
11.7.2 IQVIA Business Overview
11.7.3 IQVIA Patient Recruitment for Clinical Trials Introduction
11.7.4 IQVIA Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.7.5 IQVIA Recent Development
11.8 PPD Inc
11.8.1 PPD Inc Company Details
11.8.2 PPD Inc Business Overview
11.8.3 PPD Inc Patient Recruitment for Clinical Trials Introduction
11.8.4 PPD Inc Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.8.5 PPD Inc Recent Development
11.9 Veristat
11.9.1 Veristat Company Details
11.9.2 Veristat Business Overview
11.9.3 Veristat Patient Recruitment for Clinical Trials Introduction
11.9.4 Veristat Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.9.5 Veristat Recent Development
11.10 Elligo Health Research
11.10.1 Elligo Health Research Company Details
11.10.2 Elligo Health Research Business Overview
11.10.3 Elligo Health Research Patient Recruitment for Clinical Trials Introduction
11.10.4 Elligo Health Research Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.10.5 Elligo Health Research Recent Development
11.11 AutoCruitment
11.11.1 AutoCruitment Company Details
11.11.2 AutoCruitment Business Overview
11.11.3 AutoCruitment Patient Recruitment for Clinical Trials Introduction
11.11.4 AutoCruitment Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.11.5 AutoCruitment Recent Development
11.12 Clinical Connection
11.12.1 Clinical Connection Company Details
11.12.2 Clinical Connection Business Overview
11.12.3 Clinical Connection Patient Recruitment for Clinical Trials Introduction
11.12.4 Clinical Connection Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.12.5 Clinical Connection Recent Development
11.13 Biorasi
11.13.1 Biorasi Company Details
11.13.2 Biorasi Business Overview
11.13.3 Biorasi Patient Recruitment for Clinical Trials Introduction
11.13.4 Biorasi Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.13.5 Biorasi Recent Development
11.14 Curavit Clinical Research
11.14.1 Curavit Clinical Research Company Details
11.14.2 Curavit Clinical Research Business Overview
11.14.3 Curavit Clinical Research Patient Recruitment for Clinical Trials Introduction
11.14.4 Curavit Clinical Research Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.14.5 Curavit Clinical Research Recent Development
11.15 PatientEvolution
11.15.1 PatientEvolution Company Details
11.15.2 PatientEvolution Business Overview
11.15.3 PatientEvolution Patient Recruitment for Clinical Trials Introduction
11.15.4 PatientEvolution Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.15.5 PatientEvolution Recent Development
11.16 Trialmed
11.16.1 Trialmed Company Details
11.16.2 Trialmed Business Overview
11.16.3 Trialmed Patient Recruitment for Clinical Trials Introduction
11.16.4 Trialmed Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.16.5 Trialmed Recent Development
11.17 MMG
11.17.1 MMG Company Details
11.17.2 MMG Business Overview
11.17.3 MMG Patient Recruitment for Clinical Trials Introduction
11.17.4 MMG Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.17.5 MMG Recent Development
11.18 Science37
11.18.1 Science37 Company Details
11.18.2 Science37 Business Overview
11.18.3 Science37 Patient Recruitment for Clinical Trials Introduction
11.18.4 Science37 Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.18.5 Science37 Recent Development
11.19 StudyKIK
11.19.1 StudyKIK Company Details
11.19.2 StudyKIK Business Overview
11.19.3 StudyKIK Patient Recruitment for Clinical Trials Introduction
11.19.4 StudyKIK Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.19.5 StudyKIK Recent Development
11.20 Trialbee
11.20.1 Trialbee Company Details
11.20.2 Trialbee Business Overview
11.20.3 Trialbee Patient Recruitment for Clinical Trials Introduction
11.20.4 Trialbee Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.20.5 Trialbee Recent Development
11.21 Formation Bio
11.21.1 Formation Bio Company Details
11.21.2 Formation Bio Business Overview
11.21.3 Formation Bio Patient Recruitment for Clinical Trials Introduction
11.21.4 Formation Bio Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.21.5 Formation Bio Recent Development
11.22 WCG Clinical Services
11.22.1 WCG Clinical Services Company Details
11.22.2 WCG Clinical Services Business Overview
11.22.3 WCG Clinical Services Patient Recruitment for Clinical Trials Introduction
11.22.4 WCG Clinical Services Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.22.5 WCG Clinical Services Recent Development
11.23 Trialfacts
11.23.1 Trialfacts Company Details
11.23.2 Trialfacts Business Overview
11.23.3 Trialfacts Patient Recruitment for Clinical Trials Introduction
11.23.4 Trialfacts Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.23.5 Trialfacts Recent Development
11.24 Shanghai Jsure
11.24.1 Shanghai Jsure Company Details
11.24.2 Shanghai Jsure Business Overview
11.24.3 Shanghai Jsure Patient Recruitment for Clinical Trials Introduction
11.24.4 Shanghai Jsure Revenue in Patient Recruitment for Clinical Trials Business (2021–2026)
11.24.5 Shanghai Jsure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Clinical Trial Phase (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Key Players of Phase IV
Table 6. Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Client Type (US$ Million): 2021 vs 2025 vs 2032
Table 7. Key Players of Pharmaceutical Companies
Table 8. Key Players of Biotechnology Companies
Table 9. Key Players of CROs and Research Organizations
Table 10. Global Patient Recruitment for Clinical Trials Market Size Growth Rate by Recruitment Channel (US$ Million): 2021 vs 2025 vs 2032
Table 11. Key Players of Online
Table 12. Key Players of Offline
Table 13. Global Patient Recruitment for Clinical Trials Market Size Growth by Therapeutic Area (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Patient Recruitment for Clinical Trials Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global Patient Recruitment for Clinical Trials Market Size by Region (US$ Million), 2021–2026
Table 16. Global Patient Recruitment for Clinical Trials Market Share by Region (2021–2026)
Table 17. Global Patient Recruitment for Clinical Trials Forecasted Market Size by Region (US$ Million), 2027–2032
Table 18. Global Patient Recruitment for Clinical Trials Market Share by Region (2027–2032)
Table 19. Patient Recruitment for Clinical Trials Market Trends
Table 20. Patient Recruitment for Clinical Trials Market Drivers
Table 21. Patient Recruitment for Clinical Trials Market Challenges
Table 22. Patient Recruitment for Clinical Trials Market Restraints
Table 23. Global Patient Recruitment for Clinical Trials Revenue by Players (US$ Million), 2021–2026
Table 24. Global Patient Recruitment for Clinical Trials Market Share by Players (2021–2026)
Table 25. Global Top Patient Recruitment for Clinical Trials Players by Tier (Tier 1, Tier 2, and Tier 3), based on Patient Recruitment for Clinical Trials Revenue, 2025
Table 26. Ranking of Global Top Patient Recruitment for Clinical Trials Companies by Revenue (US$ Million) in 2025
Table 27. Global 5 Largest Players Market Share by Patient Recruitment for Clinical Trials Revenue (CR5 and HHI), 2021–2026
Table 28. Global Key Players of Patient Recruitment for Clinical Trials, Headquarters and Area Served
Table 29. Global Key Players of Patient Recruitment for Clinical Trials, Products and Applications
Table 30. Global Key Players of Patient Recruitment for Clinical Trials, Date of General Availability (GA)
Table 31. Mergers and Acquisitions, Expansion Plans
Table 32. Global Patient Recruitment for Clinical Trials Market Size by Clinical Trial Phase (US$ Million), 2021–2026
Table 33. Global Patient Recruitment for Clinical Trials Revenue Market Share by Clinical Trial Phase (2021–2026)
Table 34. Global Patient Recruitment for Clinical Trials Forecasted Market Size by Clinical Trial Phase (US$ Million), 2027–2032
Table 35. Global Patient Recruitment for Clinical Trials Revenue Market Share by Clinical Trial Phase (2027–2032)
Table 36. Global Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (US$ Million), 2021–2026
Table 37. Global Patient Recruitment for Clinical Trials Revenue Market Share by Therapeutic Area (2021–2026)
Table 38. Global Patient Recruitment for Clinical Trials Forecasted Market Size by Therapeutic Area (US$ Million), 2027–2032
Table 39. Global Patient Recruitment for Clinical Trials Revenue Market Share by Therapeutic Area (2027–2032)
Table 40. North America Patient Recruitment for Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. North America Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2021–2026
Table 42. North America Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2027–2032
Table 43. Europe Patient Recruitment for Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Europe Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2021–2026
Table 45. Europe Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2027–2032
Table 46. Asia-Pacific Patient Recruitment for Clinical Trials Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 47. Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (US$ Million), 2021–2026
Table 48. Asia-Pacific Patient Recruitment for Clinical Trials Market Size by Region (US$ Million), 2027–2032
Table 49. Latin America Patient Recruitment for Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 50. Latin America Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2021–2026
Table 51. Latin America Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2027–2032
Table 52. Middle East & Africa Patient Recruitment for Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 53. Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2021–2026
Table 54. Middle East & Africa Patient Recruitment for Clinical Trials Market Size by Country (US$ Million), 2027–2032
Table 55. Antidote Company Details
Table 56. Antidote Business Overview
Table 57. Antidote Patient Recruitment for Clinical Trials Product
Table 58. Antidote Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 59. Antidote Recent Development
Table 60. M&B Sciences Company Details
Table 61. M&B Sciences Business Overview
Table 62. M&B Sciences Patient Recruitment for Clinical Trials Product
Table 63. M&B Sciences Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 64. M&B Sciences Recent Development
Table 65. Clariness Company Details
Table 66. Clariness Business Overview
Table 67. Clariness Patient Recruitment for Clinical Trials Product
Table 68. Clariness Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 69. Clariness Recent Development
Table 70. BBK Worldwide Company Details
Table 71. BBK Worldwide Business Overview
Table 72. BBK Worldwide Patient Recruitment for Clinical Trials Product
Table 73. BBK Worldwide Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 74. BBK Worldwide Recent Development
Table 75. Worldwide Clinical Trials Company Details
Table 76. Worldwide Clinical Trials Business Overview
Table 77. Worldwide Clinical Trials Patient Recruitment for Clinical Trials Product
Table 78. Worldwide Clinical Trials Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 79. Worldwide Clinical Trials Recent Development
Table 80. American Clinical Research Services Company Details
Table 81. American Clinical Research Services Business Overview
Table 82. American Clinical Research Services Patient Recruitment for Clinical Trials Product
Table 83. American Clinical Research Services Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 84. American Clinical Research Services Recent Development
Table 85. IQVIA Company Details
Table 86. IQVIA Business Overview
Table 87. IQVIA Patient Recruitment for Clinical Trials Product
Table 88. IQVIA Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 89. IQVIA Recent Development
Table 90. PPD Inc Company Details
Table 91. PPD Inc Business Overview
Table 92. PPD Inc Patient Recruitment for Clinical Trials Product
Table 93. PPD Inc Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 94. PPD Inc Recent Development
Table 95. Veristat Company Details
Table 96. Veristat Business Overview
Table 97. Veristat Patient Recruitment for Clinical Trials Product
Table 98. Veristat Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 99. Veristat Recent Development
Table 100. Elligo Health Research Company Details
Table 101. Elligo Health Research Business Overview
Table 102. Elligo Health Research Patient Recruitment for Clinical Trials Product
Table 103. Elligo Health Research Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 104. Elligo Health Research Recent Development
Table 105. AutoCruitment Company Details
Table 106. AutoCruitment Business Overview
Table 107. AutoCruitment Patient Recruitment for Clinical Trials Product
Table 108. AutoCruitment Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 109. AutoCruitment Recent Development
Table 110. Clinical Connection Company Details
Table 111. Clinical Connection Business Overview
Table 112. Clinical Connection Patient Recruitment for Clinical Trials Product
Table 113. Clinical Connection Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 114. Clinical Connection Recent Development
Table 115. Biorasi Company Details
Table 116. Biorasi Business Overview
Table 117. Biorasi Patient Recruitment for Clinical Trials Product
Table 118. Biorasi Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 119. Biorasi Recent Development
Table 120. Curavit Clinical Research Company Details
Table 121. Curavit Clinical Research Business Overview
Table 122. Curavit Clinical Research Patient Recruitment for Clinical Trials Product
Table 123. Curavit Clinical Research Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 124. Curavit Clinical Research Recent Development
Table 125. PatientEvolution Company Details
Table 126. PatientEvolution Business Overview
Table 127. PatientEvolution Patient Recruitment for Clinical Trials Product
Table 128. PatientEvolution Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 129. PatientEvolution Recent Development
Table 130. Trialmed Company Details
Table 131. Trialmed Business Overview
Table 132. Trialmed Patient Recruitment for Clinical Trials Product
Table 133. Trialmed Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 134. Trialmed Recent Development
Table 135. MMG Company Details
Table 136. MMG Business Overview
Table 137. MMG Patient Recruitment for Clinical Trials Product
Table 138. MMG Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 139. MMG Recent Development
Table 140. Science37 Company Details
Table 141. Science37 Business Overview
Table 142. Science37 Patient Recruitment for Clinical Trials Product
Table 143. Science37 Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 144. Science37 Recent Development
Table 145. StudyKIK Company Details
Table 146. StudyKIK Business Overview
Table 147. StudyKIK Patient Recruitment for Clinical Trials Product
Table 148. StudyKIK Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 149. StudyKIK Recent Development
Table 150. Trialbee Company Details
Table 151. Trialbee Business Overview
Table 152. Trialbee Patient Recruitment for Clinical Trials Product
Table 153. Trialbee Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 154. Trialbee Recent Development
Table 155. Formation Bio Company Details
Table 156. Formation Bio Business Overview
Table 157. Formation Bio Patient Recruitment for Clinical Trials Product
Table 158. Formation Bio Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 159. Formation Bio Recent Development
Table 160. WCG Clinical Services Company Details
Table 161. WCG Clinical Services Business Overview
Table 162. WCG Clinical Services Patient Recruitment for Clinical Trials Product
Table 163. WCG Clinical Services Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 164. WCG Clinical Services Recent Development
Table 165. Trialfacts Company Details
Table 166. Trialfacts Business Overview
Table 167. Trialfacts Patient Recruitment for Clinical Trials Product
Table 168. Trialfacts Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 169. Trialfacts Recent Development
Table 170. Shanghai Jsure Company Details
Table 171. Shanghai Jsure Business Overview
Table 172. Shanghai Jsure Patient Recruitment for Clinical Trials Product
Table 173. Shanghai Jsure Revenue in Patient Recruitment for Clinical Trials Business (US$ Million), 2021–2026
Table 174. Shanghai Jsure Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
Table 178. Authors List of This Report
List of Figures
Figure 1. Patient Recruitment for Clinical Trials Picture
Figure 2. Global Patient Recruitment for Clinical Trials Market Size Comparison by Clinical Trial Phase (US$ Million), 2021–2032
Figure 3. Global Patient Recruitment for Clinical Trials Market Share by Clinical Trial Phase: 2025 vs 2032
Figure 4. Phase I Features
Figure 5. Phase II Features
Figure 6. Phase III Features
Figure 7. Phase IV Features
Figure 8. Global Patient Recruitment for Clinical Trials Market Size Comparison by Client Type (US$ Million), 2021–2032
Figure 9. Pharmaceutical Companies Features
Figure 10. Biotechnology Companies Features
Figure 11. CROs and Research Organizations Features
Figure 12. Global Patient Recruitment for Clinical Trials Market Size Comparison by Recruitment Channel (US$ Million), 2021–2032
Figure 13. Online Features
Figure 14. Offline Features
Figure 15. Global Patient Recruitment for Clinical Trials Market Size by Therapeutic Area (US$ Million), 2021–2032
Figure 16. Global Patient Recruitment for Clinical Trials Market Share by Therapeutic Area: 2025 vs 2032
Figure 17. Oncology Clinical Trials Case Studies
Figure 18. Rare Disease Clinical Trials Case Studies
Figure 19. Chronic and Common Disease Clinical Trials Case Studies
Figure 20. CNS and Psychiatric Clinical Trials Case Studies
Figure 21. Others Case Studies
Figure 22. Patient Recruitment for Clinical Trials Report Years Considered
Figure 23. Global Patient Recruitment for Clinical Trials Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 24. Global Patient Recruitment for Clinical Trials Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Patient Recruitment for Clinical Trials Market Share by Region: 2025 vs 2032
Figure 26. Global Patient Recruitment for Clinical Trials Market Share by Players in 2025
Figure 27. Global Patient Recruitment for Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Patient Recruitment for Clinical Trials Revenue in 2025
Figure 29. North America Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. North America Patient Recruitment for Clinical Trials Market Share by Country (2021–2032)
Figure 31. United States Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Canada Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Europe Patient Recruitment for Clinical Trials Market Share by Country (2021–2032)
Figure 35. Germany Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. France Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. U.K. Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Italy Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Russia Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Ireland Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Asia-Pacific Patient Recruitment for Clinical Trials Market Share by Region (2021–2032)
Figure 43. China Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Japan Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. South Korea Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Southeast Asia Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. India Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Australia & New Zealand Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Latin America Patient Recruitment for Clinical Trials Market Share by Country (2021–2032)
Figure 51. Mexico Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Brazil Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Middle East & Africa Patient Recruitment for Clinical Trials Market Share by Country (2021–2032)
Figure 55. Israel Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Saudi Arabia Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. UAE Patient Recruitment for Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Antidote Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 59. M&B Sciences Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 60. Clariness Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 61. BBK Worldwide Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 62. Worldwide Clinical Trials Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 63. American Clinical Research Services Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 64. IQVIA Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 65. PPD Inc Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 66. Veristat Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 67. Elligo Health Research Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 68. AutoCruitment Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 69. Clinical Connection Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 70. Biorasi Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 71. Curavit Clinical Research Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 72. PatientEvolution Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 73. Trialmed Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 74. MMG Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 75. Science37 Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 76. StudyKIK Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 77. Trialbee Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 78. Formation Bio Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 79. WCG Clinical Services Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 80. Trialfacts Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 81. Shanghai Jsure Revenue Growth Rate in Patient Recruitment for Clinical Trials Business (2021–2026)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed